Drug recalls

Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manuf…

Hikma Pharmaceuticals USA INC. · Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

Class IIOngoingD-0831-2026
Status
Ongoing
City
Columbus
State
OH
Country
United States
Classification
Class II
Product type
Drugs
Event ID
99711
Recalling firm
Hikma Pharmaceuticals USA INC.
Address 1
1809 Wilson Rd
Address 2
N/A
Postal code
43228-9579
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Letter
Distribution pattern
Nationwide within the United States
Recall number
D-0831-2026
Product quantity
a) 25,970 bottles; b) 2,384 bottles
Reason for recall
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
Recall initiation date
20260824
Center classification date
20260903
Report date
20260902
Code info
a) Lot #: AC5470A, Exp. Date July 2027 b) Lot #: AC5470B, Exp. Date July 2027
Product description

Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228.

Harmonized identifiers (openFDA)
Application number
ANDA077900
Brand name
RAMIPRIL
Generic name
RAMIPRIL
Manufacturer name
Exelan Pharmaceuticals, Inc.
Product NDC
76282-670, 76282-671, 76282-672, 76282-673
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
RAMIPRIL
RxCUI
198188, 198189, 261962, 845488
SPL ID
37481fc5-771f-4dc7-aa06-6913ab75d485
SPL set ID
1e1dfacf-b831-4743-a874-9a5e5ef8a120
Package NDC
76282-670-01, 76282-671-01, 76282-671-05, 76282-672-01, 76282-672-05, 76282-673-01, 76282-673-05
Is original packager
true
Upc
0376282670010, 0376282672014, 0376282673011
Nui
N0000175562, N0000000181
Pharm class epc
Angiotensin Converting Enzyme Inhibitor [EPC]
Pharm class moa
Angiotensin-converting Enzyme Inhibitors [MoA]
UNII
L35JN3I7SJ
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.